AUROBINDO PHARMA LTD. - Updates

Aurobindo Pharma Ltd has submitted to BSE a copy of the Code of Practices and Procedures for Fair Disclosure of Un-Published Price Sensitive Information formulated pursuant to the provisions of Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015 which has been approved by the Board of Directors of the Company.